Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1518 participants
OBSERVATIONAL
2021-09-27
2021-12-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Population A: patients age 65 and over treated in an oncology or oncogeriatric outpatient clinic, or seen in an oncology or oncogeriatric consultation.
* Population B: young patients age 18 to 64 treated in an oncology or outpatient clinic, or seen in an oncology consultation.
The following questionnaires:
* Approved French version of the FCCHL scale
* Questionnaire on the use of digital tools adapted from the questionnaire on digital tools,
will be completed once only. It will be completed by the participant during the oncology or oncogeriatric consultation or outpatient clinic appointment, in self-questionnaire mode or face to face, assisted if necessary by a family member or member of the medical team.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients
NCT07200453
Perceived Burden and Quality of Life of Primary Caregivers of Cancer Patients Aged 70 and Older After 5 Years of Management
NCT04478903
Which Health-care Professional(s) to Talk About Advance Care Planning ?
NCT06376799
Awareness About Breast Cancer Screening
NCT03777397
Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.
NCT05690828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Population A
65 years old and more
Questionnaires
* Approved French version of the FCCHL scale
* Questionnaire on the use of digital tools adapted from the questionnaire on digital tools
Population B
18 to 64 years old
Questionnaires
* Approved French version of the FCCHL scale
* Questionnaire on the use of digital tools adapted from the questionnaire on digital tools
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
* Approved French version of the FCCHL scale
* Questionnaire on the use of digital tools adapted from the questionnaire on digital tools
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age ≥ 18 years.
3. Patient treated for cancer.
4. Patient who can read and understand French.
5. Patient seen in an oncology or oncogeriatric consultation or treated in an outpatient clinic.
6. Patient in treatment or about to start treatment that has been offered to them, from the announcement consultation to 2 years after the start of treatment
Exclusion Criteria
2. Patient with know cognitive impairment preventing them from answering the questionnaire.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Bergonié
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pr Elene Paillaud
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01725-36
Identifier Type: OTHER
Identifier Source: secondary_id
IB 2021-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.